Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Sort By:
Jun 05, 2017
Jun 05, 2017
St. Marys, West Virginia ProtoKinetix, Incorporated (PKTX) (the “Company” or “ProtoKinetix”) ( and Proactive Immune Sciences ( today announce that they have entered into a joint research collaboration. The goal of...Read more
Jun 07, 2016
St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB:PKTX) (the “Company” or “ProtoKinetix”) ( is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix’ AAGP® has been published...Read more
Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.

Picture of a molecule
Picture of a molecule